chr16-2088661-GAAAT-G
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_000548.5(TSC2):c.*59_*62delTAAA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00264 in 1,562,330 control chromosomes in the GnomAD database, including 42 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0099 ( 20 hom., cov: 33)
Exomes 𝑓: 0.0019 ( 22 hom. )
Consequence
TSC2
NM_000548.5 3_prime_UTR
NM_000548.5 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.631
Genes affected
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 16-2088661-GAAAT-G is Benign according to our data. Variant chr16-2088661-GAAAT-G is described in ClinVar as [Likely_benign]. Clinvar id is 49664.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088661-GAAAT-G is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00988 (1493/151052) while in subpopulation AFR AF= 0.0323 (1340/41478). AF 95% confidence interval is 0.0309. There are 20 homozygotes in gnomad4. There are 696 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1493 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSC2 | NM_000548.5 | c.*59_*62delTAAA | 3_prime_UTR_variant | 42/42 | ENST00000219476.9 | NP_000539.2 | ||
PKD1 | NM_001009944.3 | c.*1062_*1065delATTT | downstream_gene_variant | ENST00000262304.9 | NP_001009944.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSC2 | ENST00000219476.9 | c.*59_*62delTAAA | 3_prime_UTR_variant | 42/42 | 5 | NM_000548.5 | ENSP00000219476.3 | |||
PKD1 | ENST00000262304.9 | c.*1062_*1065delATTT | downstream_gene_variant | 1 | NM_001009944.3 | ENSP00000262304.4 |
Frequencies
GnomAD3 genomes AF: 0.00989 AC: 1492AN: 150934Hom.: 20 Cov.: 33
GnomAD3 genomes
AF:
AC:
1492
AN:
150934
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00381 AC: 666AN: 174634Hom.: 6 AF XY: 0.00357 AC XY: 340AN XY: 95228
GnomAD3 exomes
AF:
AC:
666
AN:
174634
Hom.:
AF XY:
AC XY:
340
AN XY:
95228
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00187 AC: 2633AN: 1411278Hom.: 22 AF XY: 0.00192 AC XY: 1344AN XY: 699972
GnomAD4 exome
AF:
AC:
2633
AN:
1411278
Hom.:
AF XY:
AC XY:
1344
AN XY:
699972
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00988 AC: 1493AN: 151052Hom.: 20 Cov.: 33 AF XY: 0.00943 AC XY: 696AN XY: 73790
GnomAD4 genome
AF:
AC:
1493
AN:
151052
Hom.:
Cov.:
33
AF XY:
AC XY:
696
AN XY:
73790
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
31
AN:
3464
ClinVar
Significance: Likely benign
Submissions summary: Benign:2Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Tuberous sclerosis syndrome Benign:1Other:2
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided, no classification provided | curation | Tuberous sclerosis database (TSC2) | - | - - |
not provided, no classification provided | curation | Tuberous sclerosis database (TSC2) | - | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 30, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at